Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.64 USD | -8.57% | +8.47% | -4.05% |
Mar. 28 | North American Morning Briefing : Stocks Set for -2- | DJ |
Mar. 26 | Immunome, Inc. completed the acquisition of Assets from Ayala Pharmaceuticals, Inc.. | CI |
Chart calendar Ayala Pharmaceuticals, Inc.
Upcoming events on Ayala Pharmaceuticals, Inc.
No events available
Past events on Ayala Pharmaceuticals, Inc.
2023-10-19 | European Society for Medical Oncology Congress |
2023-08-10 04:30 pm | Q2 2023 Earnings Release |
2023-07-27 | Annual General Meeting |
2023-01-12 | Extraordinary Shareholders Meeting |
2022-09-12 06:40 pm | Q3 2022 Earnings Release |
2022-06-28 10:00 am | Annual General Meeting |
2022-06-08 08:00 am | Interim 2022 Earnings Release |
2022-06-06 02:15 pm | American Society of Clinical Oncology Meeting - Abstract Number: TPS5115 |
2022-06-06 09:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 9038 |
2022-06-06 09:00 am | American Society of Clinical Oncology Meeting - Abstract Number: 9042 |
2022-06-05 | Reverse Split: 1 of 80 |
2022-03-31 10:00 am | Extraordinary Shareholders Meeting |
2022-03-17 09:00 am | Q1 2022 Earnings Release |
2022-02-13 | FY 2021 Earnings Release |
2022-01-04 | LifeSci Partners Corporate Access Event |
2021-12-15 | Extraordinary Shareholders Meeting - Second Call |
2021-12-07 10:00 am | Extraordinary Shareholders Meeting - M&A Vote |
2021-09-10 08:30 am | Q3 2021 Earnings Release |
2021-07-06 08:30 am | Advaxis, Inc and Biosight Ltd Merger Call |
2021-06-14 04:05 pm | Interim 2021 Earnings Release |
Annual results
Fiscal Period | December | 2023 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 |
EBITDA | Released Forecast Spread | 0,00 |
EBIT | Released Forecast Spread | 0,00 |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 |
Net income | Released Forecast Spread | 0,00 |
EPS | Released Forecast Spread | 0,00 |
Announcement Date | - |
Quarterly results
Fiscal Period | December | 2023 Q2 |
---|---|---|
Net income Million USD | Released Forecast Spread | -8,70 |
EPS USD | Released Forecast Spread | -1,82 |
Announcement Date | 10/08/23 |
Past sector events for Ayala Pharmaceuticals, Inc.
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-27 | SAB BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
2024-03-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
2024-03-27 | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-26 | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-26 04:01 pm | KORRO BIO, INC.: Q4 2023 Earnings Release |
2024-03-26 06:00 am | GYRE THERAPEUTICS, INC.: Q4 2023 Earnings Release |
- Stock
- Equities
- Stock Ayala Pharmaceuticals, Inc. - OTC Markets
- Calendar Ayala Pharmaceuticals, Inc.